We are live on ! Find out more
VTGN icon

VistaGen Therapeutics
VTGN

101 hedge funds and large institutions have $387M invested in VistaGen Therapeutics in 2021 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 23 increasing their positions, 22 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 19

71% more capital invested

Capital invested by funds: $227M → $387M (+$160M)

36% more funds holding

Funds holding: 74 → 101 (+27)

5% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 22

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.31% less ownership

Funds ownership: 2.46% → 2.15% (-0.31%)

Holders
101
Holders Change
+27
Holders Change %
+36.49%
% of All Funds
1.76%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
46
Increased
23
Reduced
22
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$22.2M
2
O
OrbiMed
New York
+$14.5M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$7.6M
4
State Street
State Street
Massachusetts
+$7.56M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.88M

Top Sellers

Rank Fund Capital Flow
1
MWNA
Marshall Wace North America
New York
-$6.02M
2
GTC
Ghost Tree Capital
New York
-$5.29M
3
IC
Ikarian Capital
Texas
-$4.86M
4
Millennium Management
Millennium Management
New York
-$3.01M
5
SB
Samsara BioCapital
California
-$2.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
EI
26
EAM Investors
California
$1.24M – – –
HS
27
HighVista Strategies
Massachusetts
$971K +$761K +10,270 New
CAM
28
ClariVest Asset Management
California
$929K +$728K +9,823 New
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$832K +$652K +8,806 New
State of Wisconsin Investment Board
30
State of Wisconsin Investment Board
Wisconsin
$779K +$611K +8,247 New
Morgan Stanley
31
Morgan Stanley
New York
$660K -$1.04M -14,068 -67%
JP Morgan Chase
32
JP Morgan Chase
New York
$656K +$514K +6,941 New
AA
33
ALPS Advisors
Colorado
$588K +$461K +6,221 New
Deutsche Bank
34
Deutsche Bank
Germany
$588K +$461K +6,221 New
QI
35
QS Investors
New York
$561K +$439K +5,930 New
Millennium Management
36
Millennium Management
New York
$557K -$3.01M -40,656 -87%
OFA
37
Oak Family Advisors
Illinois
$534K +$246K +3,320 +142%
Jane Street
38
Jane Street
New York
$521K +$360K +4,858 +732%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$516K +$405K +5,463 New
MIM
40
Monashee Investment Management
Massachusetts
$495K +$388K +5,233 New
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$456K +$357K +4,825 New
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$449K +$352K +4,755 New
HighTower Advisors
43
HighTower Advisors
Illinois
$429K +$24.7K +333 +8%
DADC
44
D.A. Davidson & Co
Montana
$414K -$4.96K -67 -2%
BFM
45
Boothbay Fund Management
New York
$401K -$428K -5,777 -58%
EWA
46
Exencial Wealth Advisors
Oklahoma
$400K +$6.59K +89 +2%
Manulife (Manufacturers Life Insurance)
47
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$348K +$273K +3,682 New
AQR Capital Management
48
AQR Capital Management
Connecticut
$346K +$271K +3,657 New
Renaissance Technologies
49
Renaissance Technologies
New York
$323K +$253K +3,421 New
CSS
50
Cubist Systematic Strategies
Connecticut
$317K +$5.85K +79 +2%
1
2
3 4 5

VTGN Hedge Fund Activity: Q2 2021 in Review

101 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in VistaGen Therapeutics (VTGN) for Q2 2021, worth a combined $387M — up 71% from $227M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new VTGN positions and 19 closed out — a net gain of 27 holders — while 23 added to existing stakes and 22 trimmed.

The largest buyer was BlackRock, adding an estimated $22.2M. The largest seller was Marshall Wace North America, exiting entirely with an estimated $6.02M sold.

  • 101 institutional investors held VistaGen Therapeutics (VTGN) as of Q2 2021, up from 74 in Q1 2021.
  • Funds reported $387M of VistaGen Therapeutics stock for Q2 2021, up 71% quarter-over-quarter.
  • 46 funds opened new VistaGen Therapeutics positions in Q2 2021 and 19 closed out, a net change of +27 holders.
  • The largest VistaGen Therapeutics buyer in Q2 2021 was BlackRock, an estimated $22.2M added.
  • The largest VistaGen Therapeutics seller in Q2 2021 was Marshall Wace North America, an estimated $6.02M sold.

Based on aggregated 13F filings for Q2 2021.